首页 › 基金 › TCG Crossover Management, LLC › AKTS
TCG Crossover Management, LLC 对 AKTS 的持仓历史
AKTIS ONCOLOGY INC · 医疗保健
TCG Crossover Management, LLC 在 Q2 2026 的 13F 申报中披露持有 AKTS(AKTIS ONCOLOGY INC)696,560 股,市值约 US$22.5M,约占其申报组合的 0.54%,在其申报持仓中市值排名第 39 位。 TCG Crossover Management, LLC 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
TCG Crossover Management, LLC 对 AKTS 的持仓演变
TCG Crossover Management, LLC 于 Q2 2026 首次披露 AKTS 持仓:696,560 股(约 US$22.5M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 696.56K | $22.45M | 新进 |
关于 AKTS 与 13F 数据
AKTS(AKTIS ONCOLOGY INC)属于医疗保健行业。我们追踪的基金中还有 121 只申报持有 AKTS,申报仓位最大的包括:MPM BioImpact LLC (US$155.9M), EcoR1 Capital, LLC (US$155.5M), Blue Owl Capital Holdings LP (US$99.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AKTS 的基金
- MPM BioImpact LLC 4.84M 股 · $155.86M · Q2 2026
- EcoR1 Capital, LLC 4.82M 股 · $155.49M · Q2 2026
- Blue Owl Capital Holdings LP 3.07M 股 · $98.95M · Q2 2026
- RTW INVESTMENTS, LP 1.59M 股 · $51.31M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.31M 股 · $42.36M · Q2 2026
- BAKER BROS. ADVISORS LP 996.35K 股 · $32.11M · Q2 2026
- Octagon Capital Advisors LP 960.85K 股 · $30.97M · Q2 2026
- Merck & Co., Inc. 952.84K 股 · $30.71M · Q2 2026
- Avidity Partners Management LP 484.20K 股 · $15.61M · Q2 2026
- a16z Capital Management, L.L.C. 415.00K 股 · $13.38M · Q2 2026
更多关于 TCG Crossover Management, LLC
常见问题
How long has TCG Crossover Management, LLC held AKTS?
TCG Crossover Management, LLC has disclosed AKTS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is TCG Crossover Management, LLC's current position in AKTS?
As of Q2 2026, TCG Crossover Management, LLC holds 696.56K shares of AKTS (AKTIS ONCOLOGY INC), valued at $22.45M, representing 0.54% of its reported portfolio and ranking #39.
Has TCG Crossover Management, LLC been buying or selling AKTS?
In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC newly opened its position in AKTS.
Which other funds hold AKTS?
Other major institutional holders of AKTS include MPM BioImpact LLC, EcoR1 Capital, LLC, Blue Owl Capital Holdings LP, among 121 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.